Development of PRPK Directed Phthalimides
暂无分享,去创建一个
K. Anderson | N. Gray | Tinghu Zhang | H. Seo | T. Hideshima | S. Dhe-Paganon | Takashi Mizutani | Nicholas E. Vangos | K. Anderson
[1] E. Fischer,et al. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery , 2020, Nature Structural & Molecular Biology.
[2] L. Jones,et al. Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality. , 2020, Trends in pharmacological sciences.
[3] Christopher J. Williams,et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.
[4] D. Rhodes,et al. Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers , 2019, Molecular Cancer Research.
[5] M. Pybus,et al. Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome: case report and review of the literature , 2019, BMC Nephrology.
[6] Roland L. Dunbrack,et al. Defining a new nomenclature for the structures of active and inactive kinases , 2019, Proceedings of the National Academy of Sciences.
[7] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[8] C. Prasad,et al. Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations , 2018, Pediatric Nephrology.
[9] N. Matsumoto,et al. A familial case of Galloway-Mowat syndrome due to a novel TP53RK mutation: a case report , 2018, BMC Medical Genetics.
[10] Yong-Yeon Cho,et al. Targeting PRPK and TOPK for skin cancer prevention and therapy , 2018, Oncogene.
[11] Weiya Ma,et al. Targeting PRPK Function Blocks Colon Cancer Metastasis , 2018, Molecular Cancer Therapeutics.
[12] Jeremy F. P. Ullmann,et al. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly , 2017, Nature Genetics.
[13] A. Bode,et al. The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis , 2017, EBioMedicine.
[14] N. Munshi,et al. p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma. , 2017, Blood.
[15] M. Graille,et al. Crystal structures of the Gon7/Pcc1 and Bud32/Cgi121 complexes provide a model for the complete yeast KEOPS complex , 2015, Nucleic acids research.
[16] Christopher J. Ott,et al. The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins , 2014, Science.
[17] S. Carr,et al. Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells , 2014, Science.
[18] Patrick Forterre,et al. Functional assignment of KEOPS/EKC complex subunits in the biosynthesis of the universal t6A tRNA modification , 2013, Nucleic acids research.
[19] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[20] W. Kabsch. XDS , 2010, Acta crystallographica. Section D, Biological crystallography.
[21] D. Durocher,et al. Atomic structure of the KEOPS complex: an ancient protein kinase-containing molecular machine. , 2008, Molecular cell.
[22] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.